Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | TAK | UTHR | ||
| Company | Neurocrine Bioscienc | Takeda Pharmaceutical Ltd ADR | United Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 144.47 | 13.40 | 328.91 | ||
| High | 146.30 | 13.42 | 331.73 | ||
| Low | 143.09 | 13.24 | 326.49 | ||
| Last | 147.72 | 13.54 | 330.51 | ||
| Change | +2.03 | +0.18 | +1.35 | ||
| % Change | +1.39% | +1.35% | +0.41% | ||
| Volume | 600,000 | 4,167,400 | 300,400 | ||
| 20-Day Average Volume | 789,220 | 1,781,010 | 576,010 | ||
| Previous Close | 144.14 | 13.49 | 328.67 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 141.10 | 13.16 | 321.44 | ||
| 20-Day Raw Stochastic | 73.55% | 66.09% | 66.96% | ||
| 20-Day Relative Strength | 58.84% | 52.68% | 70.41% | ||
| Weighted Alpha | +43.40 | -13.16 | +49.08 | ||
| Today's Opinion | 100% Buy | 56% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 24% Sell | 96% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.18% since 07/12/24 | -0.60% since 07/12/24 | +2.42% since 07/12/24 | ||
| Low | 143.09 on 07/19/24 | 13.24 on 07/19/24 | 321.87 on 07/15/24 | ||
| High | 150.39 on 07/16/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | ||
| 1-Month | |||||
| %Chg | +11.33% since 06/18/24 | +5.45% since 06/18/24 | +7.55% since 06/18/24 | ||
| Low | 129.33 on 06/20/24 | 12.57 on 06/20/24 | 302.71 on 06/20/24 | ||
| High | 150.39 on 07/16/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | ||
| 3-Month | |||||
| %Chg | +10.37% since 04/19/24 | +0.91% since 04/19/24 | +38.34% since 04/19/24 | ||
| Low | 129.33 on 06/20/24 | 12.57 on 06/20/24 | 233.27 on 04/24/24 | ||
| High | 150.39 on 07/16/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | ||
| 6-Month | |||||
| %Chg | +6.06% since 01/19/24 | -9.18% since 01/19/24 | +51.10% since 01/19/24 | ||
| Low | 128.00 on 02/07/24 | 12.57 on 06/20/24 | 208.62 on 02/08/24 | ||
| High | 150.39 on 07/16/24 | 14.88 on 02/27/24 | 339.56 on 07/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,661,805 | 42,282,220 | 14,600,219 | ||
| Shares Outstanding, K | 100,637 | 3,164,837 | 44,356 | ||
| Annual Sales | 1,887,100,000 | 29,419,960,000 | 2,327,500,000 | ||
| Annual Net Income | 249,700,000 | 994,060,000 | 984,800,000 | ||
| Last Quarter Sales | 515,300,000 | 6,938,670,000 | 677,700,000 | ||
| Last Quarter Net Income | 43,400,000 | -46,010,000 | 306,600,000 | ||
| 60-Month Beta | 0.37 | 0.54 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 05/01/24 | 0.00 on 05/09/24 | 6.17 on 05/01/24 | ||
| Latest Earnings Date | 08/01/24 | 07/31/24 | 08/07/24 | ||
| Most Recent Dividend | N/A | 0.261 on 09/28/23 | N/A | ||
| Next Ex-Dividends Date | N/A | 03/27/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 39.71 | 8.65 | 15.54 | ||